# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Migraine

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 154 results.
An Open-label, Intermediate Size, Expanded Access Study of BHV-3000 in the Acute Treatment of Migraine
Status: Available
Last Changed: Sep 16, 2019
First Received: May 01, 2019
Disease(s): Migraine
Intervention(s): rimegepant
Study of Efficacy and Safety of AMG 334 in Adult Episodic Migraine Patients
Status: Recruiting
Last Changed: Oct 15, 2019
First Received: Nov 06, 2017
Disease(s): Migraine
Intervention(s): Erenumab, Placebo
Locations: Novartis Investigative Site, Caba, Buenos Aires, Argentina
Novartis Investigative Site, Caba, Buenos Aires, Argentina
Novartis Investigative Site, Caba, Buenos Aires, Argentina
Novartis Investigative Site, Buenos Aires, Argentina
Novartis Investigative Site, Buenos Aires, Argentina
... and 82 other locations.
Saline Injections for Prophylactic Treatment of Chronic Migraine
Status: Not yet recruiting
Last Changed: Apr 18, 2019
First Received: Apr 18, 2019
Disease(s): Chronic Migraine
Intervention(s): Saline injection, Placebo
Locations: Rehabilitation clinic, Southern Älvsborg Hospital, Borås, Sweden
Imaging the Migraine Brain Pre- and Post-Erenumab
Status: Recruiting
Last Changed: Apr 05, 2019
First Received: Dec 12, 2018
Disease(s): Migraine
Intervention(s): Erenumab
Locations: Mayo Clinic in Arizona, Scottsdale, Arizona, United States
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Status: Recruiting
Last Changed: Oct 04, 2019
First Received: Sep 14, 2018
Disease(s): Migraine
Intervention(s): Lasmiditan, Placebo
Locations: Rehabilitation & Neurological Services LLC, Huntsville, Alabama, United States
Barrow Neurological Institute, Phoenix, Arizona, United States
UCSD Altman Clinical & Translational Research Institute (ACTRI), La Jolla, California, United States
Colorado Neurological Institute, Englewood, Colorado, United States
Georgetown University Hospital, Washington, District of Columbia, United States
... and 142 other locations.
Introvision for Migraine and Headaches
Status: Recruiting
Last Changed: Aug 13, 2019
First Received: Apr 25, 2018
Disease(s): Migraine, Chronic Migraine
Intervention(s): Introvision: mental and emotional self-regulation
Locations: Hospital of the Ludwig-Maximilians-University, Munich, Bavaria, Germany
Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)
Status: Recruiting
Last Changed: Jul 30, 2019
First Received: Nov 16, 2016
Disease(s): Migraine
Intervention(s): Active Comparator, Sham Comparator
Locations: University of Michigan School of Dentistry, Ann Arbor, Michigan, United States
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Recruiting
Last Changed: Oct 02, 2019
First Received: Dec 17, 2018
Disease(s): Episodic Migraine
Intervention(s): Atogepant 30 mg, Atogepant 60 mg, Placebo, Atogepant 10 mg
Locations: Synexus Clinical Research US, Inc., Chandler, Arizona, United States
Alea Research Institute, Phoenix, Arizona, United States
Barrow Neurological Institute, Phoenix, Arizona, United States
Barrow Neurological Institute, Phoenix, Arizona, United States
Orange Grove Family Practice, Tucson, Arizona, United States
... and 129 other locations.
A Study of Home-Delivered Neurostimulation for Migraine
Status: Recruiting
Last Changed: Aug 14, 2019
First Received: Mar 14, 2019
Disease(s): Migraine Disorders
Intervention(s): non-invasive transcranial direct current stimulation (tDCS)
Locations: MJHS Institute for Innovation in Palliative Care, New York, New York, United States
New York Headache Center, New York, New York, United States
Telehealth Behavioral Migraine Management
Status: Not yet recruiting
Last Changed: Jun 11, 2019
First Received: Jun 11, 2019
Disease(s): Migraine
Intervention(s): Telehealth Behavioral Migraine Management